Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control
Laszlo Karai1, Dorothy C Brown, Andrew J Mannes
1National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA.
Abstract:
Control of cancer, neuropathic, and postoperative pain is frequently inadequate or compromised by debilitating side effects. Inhibition or removal of certain nociceptive neurons, while retaining all other sensory modalities and motor function, would represent a new therapeutic approach to control severe pain. The enriched expression of transient receptor potential cation channel, subfamily V, member 1 (TRPV1; also known as the vanilloid receptor, VR1) in nociceptive neurons of the dorsal root and trigeminal ganglia allowed us to test this concept. Administration of the potent TRPV1 agonist resiniferatoxin (RTX) to neuronal perikarya induces calcium cytotoxicity by opening the TRPV1 ion channel and selectively ablates nociceptive neurons. This treatment blocks experimental inflammatory hyperalgesia and neurogenic inflammation in rats and naturally occurring cancer and debilitating arthritic pain in dogs. Sensations of touch, proprioception, and high-threshold mechanosensitive nociception, as well as locomotor function, remained intact in both species. In separate experiments directed at postoperative pain control, subcutaneous administration of RTX transiently disrupted nociceptive nerve endings, yielding reversible analgesia. In human dorsal root ganglion cultures, RTX induced a prolonged increase in intracellular calcium in vanilloid-sensitive neurons, while leaving other, adjacent neurons unaffected. The results suggest that nociceptive neuronal or nerve terminal deletion will be effective and broadly applicable as strategies for pain management.
Insights
Targeting pain-sensing neurons with resiniferatoxin (RTX) offers a novel therapeutic strategy. This approach selectively eliminates nociceptive neurons, effectively managing severe pain without compromising other sensory or motor functions.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Current pain management strategies often have inadequate efficacy or debilitating side effects.
- Selective elimination of nociceptive neurons presents a promising therapeutic avenue for severe pain.
- Transient receptor potential cation channel, subfamily V, member 1 (TRPV1) is highly expressed in nociceptive neurons.
Purpose of the Study:
- To investigate the therapeutic potential of selectively ablating nociceptive neurons using TRPV1 activation.
- To evaluate the efficacy of resiniferatoxin (RTX) in controlling various types of severe pain.
Main Methods:
- Administration of RTX, a potent TRPV1 agonist, to neuronal perikarya in preclinical models (rats, dogs) and human cell cultures.
- Assessment of pain reduction, inflammatory markers, and preservation of other sensory and motor functions.
- Evaluation of RTX's effect on nociceptive nerve endings for postoperative pain control.
Main Results:
- RTX selectively ablated nociceptive neurons by inducing calcium cytotoxicity via TRPV1 channel opening.
- Successful blockade of inflammatory hyperalgesia, neurogenic inflammation, cancer pain, and arthritic pain in animal models.
- Preservation of touch, proprioception, mechanosensation, and motor function.
- Reversible analgesia achieved through transient disruption of nociceptive nerve endings in postoperative pain models.
- Selective calcium increase in vanilloid-sensitive neurons in human dorsal root ganglion cultures.
Conclusions:
- Selective deletion of nociceptive neurons or their terminals is a viable and broadly applicable strategy for pain management.
- TRPV1-targeted therapy with RTX demonstrates significant potential for treating diverse and severe pain conditions.
- This approach offers a new paradigm for pain control with preserved essential sensory and motor functions.
Related Concept Videos
Thermosensation
Nociception
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Opioid Receptors: Overview
Analgesia and Pain Management
Pain


